Medication info
Lipitab 2 mg (Pitavastatin Calcium Hydrate)

Lipitab 2 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2mg / 1 tablet
Manufacturer / importer
Geonil Pharmaceutical Co., Ltd.
Appearance
Very light yellowish-red round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201907243 · Approved 2019.10.15 · Insurance code 646803110

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Geonil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • apolipoprotein B
  • triglycerides
View approved original text

This medication helps effectively regulate cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Specifically, it lowers the levels of total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides, while increasing the levels of HDL cholesterol, known as 'good' cholesterol. Such effects play an important role in reducing the risk of cardiovascular diseases when used as an adjunct to dietary therapy. This medication will assist patients in improving their blood lipid status and maintaining their health. It is used for individuals who wish to safely and effectively manage dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be administered to certain patients. It should not be used in patients who are allergic to any component of this medication, patients with liver function issues or severe liver diseases, and those with bile flow obstruction. Additionally, it should not be given to patients taking cyclosporine, patients with myopathy, pregnant or potentially pregnant women, nursing mothers, and children. Patients with renal dysfunction or a history of liver disorders, those excessively consuming alcohol, and those taking certain medications should use this medication cautiously. In particular, caution is necessary when taken with fibrate agents or niacin, as there is a higher risk of muscle damage and renal function deterioration. During the use of this medication, abnormal symptoms such as muscle pain, weakness, abdominal pain, rash, and itching may occur. Liver function abnormalities, abnormal blood test results, and rarely, severe muscle damage known as rhabdomyolysis may occur, so any unusual symptoms should be immediately discussed with a physician. As this medication is mainly metabolized in the liver, regular liver function tests should be conducted, and if liver function worsens, the medication should be discontinued. Moreover, treatment should be stopped, and a physician should be consulted if symptoms such as muscle pain or muscle weakness appear. This medication should not be administered to pregnant or nursing women, and women of childbearing potential must confirm pregnancy status before taking it. This medication may interact with other drugs, so it is important to notify your doctor or pharmacist of any other medications you are taking. Particular caution is required when taken in combination with cyclosporine, fibrate drugs, niacin, and erythromycin. Elderly patients may experience side effects more easily due to reduced body function, so dosage adjustments and caution are necessary. This medication has not been established for safety and efficacy in children, and therefore should not be used in this population. Lastly, this medication should be stored in its original container and kept out of reach of children, as transferring it to another container may pose risks of accidents or quality deterioration.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • acute renal failure
Show 66 more
  • jaundice
  • thrombocytopenia
  • urticaria
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • polyuria
  • increased BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing impairment
  • hematuria
  • increased uric acid level
  • elevated serum potassium and phosphorus
  • taste disturbance
  • positive antinuclear antibody
  • facial edema
  • arm edema
  • hypersensitivity
  • paresthesia
  • loss of appetite
  • increased blood pressure
  • discomfort in the chest
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that does not allow light to enter. Additionally, it is best to store the medication at room temperature, between 1°C and 30°C, avoiding very hot or very cold areas.

Appearance and packaging

Appearance

Very light yellowish-red round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.